180 related articles for article (PubMed ID: 29569716)
1. Genetic and clonal dissection of osteosarcoma progression and lung metastasis.
Xu H; Zhu X; Bao H; Wh Shek T; Huang Z; Wang Y; Wu X; Wu Y; Chang Z; Wu S; Tang Q; Zhang H; Han A; Mc Cheung K; Zou C; Yau R; Ho WY; Huang G; Batalha S; Lu J; Song G; Kang Y; Shao YW; Lam YL; Shen J; Wang J
Int J Cancer; 2018 Sep; 143(5):1134-1142. PubMed ID: 29569716
[TBL] [Abstract][Full Text] [Related]
2. Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases.
Wang D; Niu X; Wang Z; Song CL; Huang Z; Chen KN; Duan J; Bai H; Xu J; Zhao J; Wang Y; Zhuo M; Xie XS; Kang X; Tian Y; Cai L; Han JF; An T; Sun Y; Gao S; Zhao J; Ying J; Wang L; He J; Wang J
Cancer Res; 2019 Jan; 79(1):7-20. PubMed ID: 30389703
[TBL] [Abstract][Full Text] [Related]
3. The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses.
Salinas-Souza C; De Oliveira R; Alves MT; Garcia Filho RJ; Petrilli AS; Toledo SR
Hum Pathol; 2013 Oct; 44(10):2188-98. PubMed ID: 23845465
[TBL] [Abstract][Full Text] [Related]
4. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma.
Negri GL; Grande BM; Delaidelli A; El-Naggar A; Cochrane D; Lau CC; Triche TJ; Moore RA; Jones SJ; Montpetit A; Marra MA; Malkin D; Morin RD; Sorensen PH
J Pathol; 2019 Nov; 249(3):319-331. PubMed ID: 31236944
[TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA FER1L4 Suppresses Tumorigenesis by Regulating the Expression of PTEN Targeting miR-18a-5p in Osteosarcoma.
Fei D; Zhang X; Liu J; Tan L; Xing J; Zhao D; Zhang Y
Cell Physiol Biochem; 2018; 51(3):1364-1375. PubMed ID: 30481787
[TBL] [Abstract][Full Text] [Related]
6. The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment.
Brady SW; Ma X; Bahrami A; Satas G; Wu G; Newman S; Rusch M; Putnam DK; Mulder HL; Yergeau DA; Edmonson MN; Easton J; Alexandrov LB; Chen X; Mardis ER; Wilson RK; Downing JR; Pappo AS; Raphael BJ; Dyer MA; Zhang J
Mol Cancer Res; 2019 Apr; 17(4):895-906. PubMed ID: 30651371
[TBL] [Abstract][Full Text] [Related]
7. PTEN loss activates a functional AKT/CXCR4 signaling axis to potentiate tumor growth and lung metastasis in human osteosarcoma cells.
Xi Y; Qi Z; Ma J; Chen Y
Clin Exp Metastasis; 2020 Feb; 37(1):173-185. PubMed ID: 31571016
[TBL] [Abstract][Full Text] [Related]
8. From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma.
Dean DC; Shen S; Hornicek FJ; Duan Z
Cancer Metastasis Rev; 2018 Dec; 37(4):719-731. PubMed ID: 30167827
[TBL] [Abstract][Full Text] [Related]
9. A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity.
Zhang Y; Liu Z; Zhong Z; Ji Y; Guo H; Wang W; Chen C
J Exp Clin Cancer Res; 2024 Feb; 43(1):52. PubMed ID: 38383479
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones.
Macklin R; Wang H; Loo D; Martin S; Cumming A; Cai N; Lane R; Ponce NS; Topkas E; Inder K; Saunders NA; Endo-Munoz L
Oncotarget; 2016 Jul; 7(28):43570-43587. PubMed ID: 27259278
[TBL] [Abstract][Full Text] [Related]
11. miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.
Berlanga P; Muñoz L; Piqueras M; Sirerol JA; Sánchez-Izquierdo MD; Hervás D; Hernández M; Llavador M; Machado I; Llombart-Bosch A; Cañete A; Castel V; Font de Mora J
Mol Oncol; 2016 Aug; 10(7):1043-53. PubMed ID: 27155790
[TBL] [Abstract][Full Text] [Related]
12. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
[TBL] [Abstract][Full Text] [Related]
13. Association between PTEN and clinical-pathological features of osteosarcoma.
Zhou J; Xiao X; Wang W; Luo Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31270249
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma.
Goeman F; De Nicola F; Scalera S; Sperati F; Gallo E; Ciuffreda L; Pallocca M; Pizzuti L; Krasniqi E; Barchiesi G; Vici P; Barba M; Buglioni S; Casini B; Visca P; Pescarmona E; Mazzotta M; De Maria R; Fanciulli M; Ciliberto G; Maugeri-Saccà M
J Thorac Oncol; 2019 Nov; 14(11):1924-1934. PubMed ID: 31323387
[TBL] [Abstract][Full Text] [Related]
15. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma.
Jiang Y; Li F; Gao B; Ma M; Chen M; Wu Y; Zhang W; Sun Y; Liu S; Shen H
Theranostics; 2021; 11(8):3868-3881. PubMed ID: 33664867
[No Abstract] [Full Text] [Related]
16. Rapid progressive lung cancers harbouring multiple clonal driver mutations with big bang evolution model.
Kunimasa K; Hirotsu Y; Nakamura H; Tamiya M; Iijima Y; Ishida H; Hamamoto Y; Maniwa T; Kimura T; Nishino K; Goto T; Amemiya K; Mochizuki H; Oyama T; Nakatsuka SI; Kumagai T; Okami J; Higashiyama M; Imamura F; Omata M
Cancer Genet; 2020 Feb; 241():51-56. PubMed ID: 31917104
[TBL] [Abstract][Full Text] [Related]
17. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX
Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
[TBL] [Abstract][Full Text] [Related]
19. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
Koshkina N; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
[TBL] [Abstract][Full Text] [Related]
20. Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy.
Zhao J; Dean DC; Hornicek FJ; Yu X; Duan Z
Cancer Lett; 2020 Apr; 474():158-167. PubMed ID: 31987920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
